Genscript Biotech Corporation (HKG:1548)
Hong Kong · Delayed Price · Currency is HKD 12.31
+0.28 (2.33%)
Feb 23, 2026, 4:08 PM HKT
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of 26.92 billion as of February 23, 2026. Its market cap has increased by 18.98% in one year.
Market Cap
26.92B
Enterprise Value
23.90B
Revenue
6.50B
Ranking
n/a
PE Ratio
1.10
Stock Price
12.31
Market Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 26.92B, an increase of 1,174.43%. That is a compound annual growth rate of 28.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 26.30B | -3.13% |
| Dec 31, 2025 | 27.15B | 28.72% |
| Dec 31, 2024 | 21.10B | -49.96% |
| Dec 29, 2023 | 42.16B | -19.78% |
| Dec 30, 2022 | 52.56B | -27.50% |
| Dec 31, 2021 | 72.50B | 229.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Henlius Biotech | 39.27B |
| Shanghai Junshi Biosciences | 35.38B |
| Biocytogen Pharmaceuticals (Beijing) | 34.58B |
| Duality Biotherapeutics | 31.46B |
| TransThera Sciences (Nanjing) | 26.57B |
| InnoCare Pharma | 25.34B |
| PegBio | 24.48B |
| Ascletis Pharma | 18.74B |